Biomaterial Database

Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. 1992

J P Kinsella, and S R Neish, and E Shaffer, and S H Abman

Department of Pediatrics, Children's Hospital, Denver, Colorado 80218-1088.

We studied the effects of inhaled nitric oxide (NO) in 9 newborn infants with severe persistent pulmonary hypertension (PPHN) who were candidates for extracorporeal membrane oxygenation treatment. With low doses of NO (10-20 ppm) all showed rapid improvement in oxygenation without reduction of systemic blood pressure. In 6 infants treated with inhaled NO for 24 h, clinical improvement was sustained at 6 ppm.

UI	MeSH Term	Description	Entries
D007231	Infant, Newborn	An infant during the first 28 days after birth.	Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008706	Methemoglobin		Ferrihemoglobin
D009569	Nitric Oxide	A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP.	Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010100	Oxygen	An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration.	Dioxygen,Oxygen-16,Oxygen 16
D010547	Persistent Fetal Circulation Syndrome	A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).	Fetal Circulation, Persistent,Hypertension, Pulmonary, of Newborn, Persistent,Persistent Pulmonary Hypertension of Newborn,ACD-MPV,ACDMPV,Alveolar Capillary Dysplasia With Misalignment Of Pulmonary Veins,Alveolar Capillary Dysplasia With Misalignment Of Pulmonary Veins And Other Congenital Anomalies,Circulation, Persistent Fetal,Familial Persistent Pulmonary Hypertension of the Newborn,Misalignment of the Pulmonary Vessels,Persistent Fetal Circulation,Pulmonary Hypertension, Familial Persistent, of the Newborn,ACD MPV
D001794	Blood Pressure	PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.	Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002245	Carbon Dioxide	A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals.	Carbonic Anhydride,Anhydride, Carbonic,Dioxide, Carbon
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280	Administration, Inhalation	The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.	Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D015199	Extracorporeal Membrane Oxygenation	Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of SMOKE INHALATION INJURY; RESPIRATORY FAILURE; and CARDIAC FAILURE.	ECMO Extracorporeal Membrane Oxygenation,Oxygenation, Extracorporeal Membrane,Venoarterial ECMO,Venoarterial Extracorporeal Membrane Oxygenation,Venovenous ECMO,Venovenous Extracorporeal Membrane Oxygenation,ECLS Treatment,ECMO Treatment,Extracorporeal Life Support,ECLS Treatments,ECMO Treatments,ECMO, Venoarterial,ECMO, Venovenous,Extracorporeal Life Supports,Extracorporeal Membrane Oxygenations,Life Support, Extracorporeal,Membrane Oxygenation, Extracorporeal,Treatment, ECLS,Treatment, ECMO,Venoarterial ECMOs,Venovenous ECMOs

Related Publications

J P Kinsella, and S R Neish, and E Shaffer, and S H Abman

Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.

February 2000, The New England journal of medicine,

J P Kinsella, and S R Neish, and E Shaffer, and S H Abman

[Nitric oxide in persistent pulmonary hypertension of the newborn].

January 1996, Jornal de pediatria,

J P Kinsella, and S R Neish, and E Shaffer, and S H Abman

[Nitric oxide inhalation in newborn infants with pulmonary hypertension].

January 1998, Nederlands tijdschrift voor geneeskunde,

J P Kinsella, and S R Neish, and E Shaffer, and S H Abman

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.

October 1992, Lancet (London, England),

J P Kinsella, and S R Neish, and E Shaffer, and S H Abman

Nitric oxide therapy for persistent pulmonary hypertension of the newborn.

December 1995, Neonatal network : NN,

J P Kinsella, and S R Neish, and E Shaffer, and S H Abman

Inodilators in nitric oxide resistant persistent pulmonary hypertension of the newborn.

January 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,

J P Kinsella, and S R Neish, and E Shaffer, and S H Abman

Inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn.

August 1995, Acta paediatrica Japonica : Overseas edition,

J P Kinsella, and S R Neish, and E Shaffer, and S H Abman

Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn.

May 1993, Pediatrics,

J P Kinsella, and S R Neish, and E Shaffer, and S H Abman

Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn.

February 2018, Pediatrics and neonatology,

J P Kinsella, and S R Neish, and E Shaffer, and S H Abman

Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up.

June 2003, Journal of perinatology : official journal of the California Perinatal Association,